Focused Ultrasound Amygdala Neuromodulation
NCT: NCT05228964 · COMPLETED
Brief Summary
The purpose of the study is to examine the feasibility and potential efficacy of low-intensity focused ultrasound as a method of modulating amygdala function to promote improvements in symptoms of an affective disorder. Ultrasound is frequently and safely utilized for diagnostic purposes. In this study, the investigators will utilize magnetic resonance imaging (MRI) and neuronavigation to target the left amygdala and apply ultrasound. This will be conducted once a day, 5 days a week, for 3 weeks. This will be an open-label, single-arm trial.
Frequently Asked Questions
What is Focused Ultrasound Amygdala Neuromodulation?
Focused Ultrasound Amygdala Neuromodulation is a clinical trial registered under NCT05228964. Current status: COMPLETED.
What is the status of NCT05228964?
The current status of NCT05228964 (Focused Ultrasound Amygdala Neuromodulation) is: COMPLETED.
When did Focused Ultrasound Amygdala Neuromodulation start?
Focused Ultrasound Amygdala Neuromodulation started on 2022-01-13.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.